Abstract

Background Patients with unrecognised colonisation with multi-drug resistant Gram-negative bacteria (MDRGNB) constitute a reservoir of organisms that can precede invasive disease and potentially be transmitted to other patients. A large percentage of patients colonised with these resistant bacteria are not recognised by clinical cultures but are only detected by performing surveillance cultures. 1 Aims To validate an active surveillance screening method to detect MDRGNB. Methods An agar-based method was trialled to detect MDRGNB. The media was tested against known susceptible and resistant organisms, mixed cultures, and clinical urine and rectal swab specimens. A low-risk ethics application was obtained. Results A selection of different media was used with each testing isolate: MacConkey agar (MCA) with gentamicin 8 mg/L, MCA with ciprofloxacin 2 mg/L, MCA with ceftazidime 2 mg/L and ESBL CHROMagar1. MCA without antibiotic addition was used as a control. The media was tested across 50 different specimens. Discussion We have demonstrated a reliable and practical method to screen for MDRGNB. This methodology can be utilised for an active surveillance study to establish colonisation rates with MDRGNB.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.